Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University481 Fudan University478 Second Affiliated Hospital, Zhejiang University, School of Medicine401 Ruijin Hospital289 Peking Union Medical College Hospital279
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials in this register

19187 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
NCT07822737Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography
Beijing Chao Yang Hospital
Observational
500
Beijing
2025-01-18
Recruiting
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2025-01-18
Not yet open
Second Affiliated Hospital of Soochow University
Not applicable
200
Suzhou
2025-01-18
Active, closed
Daihong Liu
Phase 1
30
Beijing
2025-01-17
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent, Urothelial Carcinoma of the Renal Pelvis and Ureter
Drugs9MW2821·JS001·Toripalimab
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
60
Changsha, Nanjing
2025-01-17
Recruiting
The Second Hospital of Hebei Medical University
Not applicable
39
Hebei
2025-01-17
Recruiting
Yunnan Cancer Hospital
Observational
40
Kunming
2025-01-17
Recruiting
Fudan University
Observational
1,000,000
Shanghai
2025-01-17
Recruiting
Akeso
Phase 1/2
280
Beijing
2025-01-17
Recruiting
The First Hospital of Jilin University
Not applicable
40
Changchun
2025-01-17
Recruiting
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06761846Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
DrugSintilimab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
70
Beijing
2025-01-17
Active, closed
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Active, closed
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
320
Chengdu
2025-01-17
Recruiting
Hangzhou Hanx Biopharmaceuticals, Ltd.
Phase 1/2
124
Beijing
2025-01-17
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
27
Guangzhou
2025-01-16
Recruiting
Tongji Hospital
Observational
20
Wuhan
2025-01-16
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
456
Guangzhou
2025-01-16
Recruiting
Hong Chen
Early Phase 1
6
Wuhan
2025-01-16
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Active, closed
Gan & Lee Pharmaceuticals.
Phase 3
274
Beijing
2025-01-16
By invitation
Capital Medical University
Not applicable
750
Beijing
2025-01-16
Recruiting
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
NCT06775743NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University
Phase 2
53
Shanghai
2025-01-15
Recruiting
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
NCT06776510Immune Thrombocytopenia, Treatment
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
20
Tianjin
2025-01-15
Not yet open
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273Arrhythmia, Acute Cerebrovascular Disease
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2025-01-15
Recruiting
Beidahuang Industry Group General Hospital
Not applicable
200
Harbin
2025-01-15
Recruiting
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
NCT06758713Multiple Myeloma, B-cell Lymphoma, Hematological Malignancy
DrugCar-T
The Third Affiliated Hospital of Southern Medical University
Phase 1
60
Guangzhou
2025-01-15
Not yet open
Henan Cancer Hospital
Phase 2
250
Luoyang, Xinxiang, Zhengzhou
2025-01-15
Recruiting
First Affiliated Hospital of Ningbo University
Phase 2
50
Ningbo
2025-01-15
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
808
Jinan
2025-01-15
By invitation
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
150
Xi'an
2025-01-15
Recruiting
The Third Xiangya Hospital of Central South University
Not applicable
200
Changsha
2025-01-15
Recruiting
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
NCT06755840Sleep Disordered Breathing (SDB), Sleep Apnea, Cardiometabolic Diseases, Multimorbidity
Xiangya Hospital of Central South University
Observational
15,000
Changsha
2025-01-15
Not yet open
Peking University Cancer Hospital & Institute
Phase 2
70
Beijing
2025-01-15
Not yet open
RenJi Hospital
Not applicable
1,976
Shanghai
2025-01-15
Not yet open
Zhejiang University
Phase 2
43
Hangzhou
2025-01-15
Recruiting
Study on the Mechanism of Acquired Resistance of Entrectinib
NCT07199959ROS1 Fusion Positive, Non Small Cell Lung Cancer
DrugEntrectinib
Fudan University
Observational
38
Shanghai
2025-01-15
Recruiting
The Third Xiangya Hospital of Central South University
Not applicable
200
Changsha
2025-01-15
Active, closed
Artificial Intelligence-assisted Diagnosis
NCT06783933Congenital Heart Disease (CHD), Structural Heart Disease
China National Center for Cardiovascular Diseases
Observational
60,000
Beijing
2025-01-15
Active, closed
argenx
Phase 3
631
Bengbu, Hefei, Guangzhou, Nanning, Guiyang, Shijiazhuang, Luoyang, Xinxiang
2025-01-15
Recruiting
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
NCT06756269HPV Infection, HPV-Related Carcinoma, HPV-Related Intraepithelial Neoplasia, Genital Wart
Shanghai Bovax Biotechnology Co., Ltd.
Phase 2
330
Nanning
2025-01-15
Recruiting
Beijing Anzhen Hospital
Observational
150
Beijing
2025-01-15
By invitation
Genecombio Ltd.
Not applicable
6
Hangzhou
2025-01-15
Not yet open
Peking University Third Hospital
Observational
300
Beijing
2025-01-15
Recruiting
Dietary Supplements to Treat Radiation-Induced Rectal Injury
NCT06776016Radiotherapy, Radiation Proctitis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
33
Guangzhou
2025-01-15
Recruiting
A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL
NCT06855823Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Sun Yat-sen University
Phase 1/2
33
Guangzhou
2025-01-14
Recruiting
Luye Pharma Group Ltd.
Phase 1/2
120
Shanghai
2025-01-14
Recruiting
A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT06820268B-cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
168
Beijing, Guangdong, Hebei, Hubei
2025-01-14
Recruiting
Grit Biotechnology
Phase 1
30
Wuhan
2025-01-14
Active, closed
Guangzhou Women and Children's Medical Center
Early Phase 1
8
Guangzhou
2025-01-14
Recruiting
Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
NCT06466083Postoperative Delirium, Postoperative Neurocognitive Disorder, Spinal Surgery
Xuanwu Hospital, Beijing
Observational
165
Beijing
2025-01-14
Recruiting
LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
NCT06788002Nasopharyngeal Cancinoma (NPC)
Hunan Cancer Hospital
Phase 2
26
Changsha, Chenzhou, Huaihua, Shaoyang, Yueyang
2025-01-14
Active, closed
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
537
Beijing
2025-01-13
Not yet open
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
NCT06779344Acute Exacerbation Chronic Obstructive Pulmonary Disease
Capital Medical University
Not applicable
458
Beijing
2025-01-13
Recruiting
Shanghai Auzone Biological Technology Co., Ltd.
Phase 2
150
Beijing, Changsha, Chengdu, Nanjing, Tianjin
2025-01-13
Recruiting
Multi-center Clinical Study on Hemoperfusion of KHA80
NCT06233838Uremia, Uremic Osteodystrophy, Dialysis Related Complication
First Affiliated Hospital of Fujian Medical University
Not applicable
394
Fuzhou
2025-01-13
Recruiting
Cisen Pharmaceutical CO., LTD.
Phase 2
108
Beijing
2025-01-13
Recruiting
Beijing Tiantan Hospital
Phase 4
128
Beijing
2025-01-10
Recruiting
Hebei Senlang Biotechnology Inc., Ltd.
Phase 2
59
Beijing
2025-01-10
Recruiting
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Mental Disorders
Central South University
Observational
200
Changsha
2025-01-10
By invitation
Fuzhou Eye Hospital
Observational
600
Fuzhou
2025-01-10
Recruiting
Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation
NCT06515132Disorder of Consciousness, Spinal Cord Stimulation
Huashan Hospital
Not applicable
50
Fuzhou, Changsha, Shanghai
2025-01-10
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
42
Xi'an
2025-01-10
Recruiting
Sun Yat-sen University
Phase 1/2
112
Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai, Guilin, Ganzhou, Nanchang
2025-01-10
Not yet open
Zhejiang University
Early Phase 1
6
Hangzhou
2025-01-10
Recruiting
Peking University People's Hospital
Not applicable
81
Beijing
2025-01-10
Recruiting
Zhejiang University
Early Phase 1
27
Hangzhou
2025-01-10
Active, closed
Tsinghua University
Not applicable
900
Beijing, Shanghai
2025-01-10
Recruiting
Zhejiang University
Phase 1
12
Hangzhou
2025-01-10
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 3
284
Tianjin
2025-01-10
Recruiting
BeOne Medicines
Phase 1
695
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou, Nanning
2025-01-10
Recruiting
Fortvita Biologics (USA)Inc.
Phase 1
250
Hefei, Beijing, Fuzhou, Nanning, Harbin, Anyang, Luoyang, Zhengzhou
2025-01-10
Recruiting
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
NCT06766422Unruptured Cerebral Aneurysm, Artificial Intelligence (AI), Subarachnoid Hemorrhage, Aneurysmal, Magnetic Resonance Angiography
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
10,000
Shanghai
2025-01-10
Recruiting
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
NCT07748325Non-Small Cell Lung Cancer, Adjuvant Therapy, Immune Checkpoint Inhibitors
DrugSintilimab
Sichuan University
Phase 2
100
Chengdu, Suining
2025-01-10
Recruiting
Chengdu Brilliant Pharmaceutical Co., Ltd.
Phase 1
48
Beijing
2025-01-10
Recruiting
First Affiliated Hospital of Chongqing Medical University
Phase 1
18
Chongqing
2025-01-10
By invitation
Shaanxi Giant Biotechnology Co., Ltd
Not applicable
244
Beijing
2025-01-10
Not yet open
Capital Medical University
Early Phase 1
6
Beijing
2025-01-10
Recruiting
Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs
NCT06754956High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
100
Shanghai
2025-01-10
Not yet open
Beijing Anzhen Hospital
Phase 4
30
Beijing
2025-01-10
Recruiting
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 3
228
Bengbu, Fuyang, Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou
2025-01-10
By invitation
Peking University People's Hospital
Observational
100
Beijing
2025-01-09
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
208
Shanghai
2025-01-09
Recruiting
Fudan University
Phase 3
1,388
Shanghai
2025-01-09
Recruiting
Peking Union Medical College Hospital
Not applicable
40
Beijing, Wenzhou
2025-01-09
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guiyang
2025-01-09
Active, closed
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
NCT06711523Neutropenia, Chemotherapy-Induced Febrile, Breast Neoplasm Female
Kexing Biopharm Co., Ltd.
Phase 3
250
Beijing
2025-01-09
Recruiting
The Second Affiliated Hospital of Chongqing Medical University
Phase 4
264
Chongqing
2025-01-09
Active, closed
TJ Biopharma Co., Ltd.
Phase 2
150
Beijing, Binzhou, Chengdu, Chongqing, Ha’erbin, Hefei, Jiangmen, Kunming
2025-01-09
Recruiting
Huashan Hospital
Early Phase 1
10
Shanghai
2025-01-09
Recruiting
AI Model for Assessing Cardiac Surgeons' Techniques
NCT06739005CABG-patients, CABG, Cardiovascular Surgery, Surgeons
China National Center for Cardiovascular Diseases
Observational
284
Beijing
2025-01-09
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Recruiting
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06418061Unresectable, Locally Advanced or Metastatic Solid Tumors
DrugIBI3005
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
198
Jinan
2025-01-08
Recruiting
Fudan University
Phase 1/2
74
Shanghai
2025-01-08
Recruiting
Zhifeng Tian,MD
Phase 2
38
Lishui
2025-01-08
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Nanjing
2025-01-08
By invitation
Oriental Neurosurgery Evidence-Based-Study Team
Not applicable
45
Tianjin
2025-01-08
Recruiting
Hangzhou Hanx Biopharmaceuticals, Ltd.
Phase 1/2
72
Beijing
2025-01-08
Recruiting
CD (Suzhou) Biopharma Co., Ltd.
Phase 1
137
Tianjin
2025-01-08
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2025-01-08
Recruiting
First Affiliated Hospital of Harbin Medical University
Not applicable
20
Harbin
2025-01-07
Recruiting
Peking University Cancer Hospital & Institute
Phase 2
60
Beijing
2025-01-07
Recruiting
BioNTech SE
Phase 2/3
1,580
Baoding, Beijing, Bengbu, Changchun, Changsha, Hangzhou, Jiamusi, Jinan
2025-01-07
Recruiting
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, Ürümqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Henan Genuine Biotech Co., Ltd.
Phase 1
48
Harbin, Jinan, Shanghai, Xinxiang
2025-01-07
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
NCT06669182Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum
Xijing Hospital
Not applicable
100
Xi'an
2025-01-07
Recruiting
RenJi Hospital
Observational
220
Shanghai
2025-01-06
Recruiting
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
NCT06754371Postpartum Hemorrhage, Systemic Autoimmune Diseases
DrugTranexamic Acid
RenJi Hospital
Phase 4
276
Shanghai
2025-01-06
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 4
40
Chengde, Shijiazhuang
2025-01-06
By invitation
Peking University Third Hospital
Observational
80
Chongli
2025-01-06
Recruiting
BeBetter Med Inc
Phase 3
416
Beijing
2025-01-06
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Recruiting
Fan BiFa
Not applicable
1
Beijing
2025-01-06
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
116
Hangzhou
2025-01-06
Active, closed
Daiichi Sankyo
Phase 2
335
Changsha, Shanghai
2025-01-06
Recruiting
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
NCT06614270Systemic Sclerosis (SSc), ANCA Associated Vasculitis (AAV), Idiopathic Inflammatory Myopathy (IIM), Sjogren's Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
15
Hangzhou
2025-01-06
Active, closed
Pfizer
Phase 3
1,035
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Nanning, Harbin, Wuhan
2025-01-06
Recruiting
First Affiliated Hospital of Guangxi Medical University
Observational
500
Nanning, Qinzhou, Wuzhou, Yulin, Suzhou
2025-01-06
Recruiting
Qilu Hospital of Shandong University
Not applicable
90
Jinan
2025-01-06
Recruiting
Tonghua Dongbao Pharmaceutical Co.,Ltd
Phase 2
276
Changsha
2025-01-06
Not yet open
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2025-01-06
Recruiting
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
NCT06767007Unresectable Locally Recurrent Rectal Cancer
DrugSerplulimab
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
31
Guangzhou
2025-01-06
Not yet open
Capital Medical University
Not applicable
372
Beijing
2025-01-05
Recruiting
Personalized DBS Targeting for Treating Depression
NCT06784388Treatment-resistant Depression (TRD)
DrugEsketamine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Early Phase 1
5
Hangzhou
2025-01-05
Active, closed
Guangdong Provincial People's Hospital
Phase 2
138
Guangzhou
2025-01-05
Recruiting
Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion
NCT06772038Hemodynamic, Fluid Responsiveness, Venous Congestion, Fluid Challenge
Bicetre Hospital
Observational
64
Guangzhou, Shenzhen
2025-01-05
Active, closed
Children's Hospital of Fudan University
Observational
1,000
Shanghai
2025-01-05
Recruiting
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NCT06012760Anemia, Iron Deficiency Anemia, Perioperative, Transfusion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hangzhou
2025-01-04
Recruiting
Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects
NCT06935682Healthy Adult Male and Female Volunteers
DrugY-4 tables
Beijing Tiantan Hospital
Phase 1
36
Beijing
2025-01-04
Recruiting
Zhejiang Cancer Hospital
Phase 2
20
Zhejiang
2025-01-04
Recruiting
Capital Medical University
Not applicable
550
Linyi
2025-01-04
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-01-03
Recruiting
CASI pharmaceuticals, Inc.
Phase 1/2
75
Tangshan, Zhengzhou, Nanchang, Jinan, Tianjin, Kunming
2025-01-03
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
47
Nanjing
2025-01-03
Recruiting
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
NCT06764238Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
DrugsBlinatumomab·Methotrexate·Vincristine·Venetoclax
Institute of Hematology & Blood Diseases Hospital, China
Phase 2/3
1,800
Hefei, Fuzhou, Guangzhou, Nanning, Guiyang, Wuhan, Changsha, Nanjing
2025-01-03
Recruiting
Third Affiliated Hospital, Sun Yat-Sen University
Observational
16,300
Guangzhou, Zhuhai
2025-01-03
Recruiting
Sun Yat-sen University
Phase 2
47
Guangzhou
2025-01-03
Recruiting
Pancreatic Cancer and Diabetes Mellitus
NCT06585072Pancreatic Cancer, Surgery, Diabetes Mellitus
Shanghai Changzheng Hospital
Observational
150
Shanghai
2025-01-03
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
460
Beijing
2025-01-03
Recruiting
Sun Yat-sen University
Phase 2
76
Lanzhou, Guangzhou, Zhengzhou
2025-01-03
Active, closed
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
207
Beijing
2025-01-03
Recruiting
Nanfang Hospital, Southern Medical University
Observational
268
Guangzhou
2025-01-03
Recruiting
Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction
NCT06748677Nipple-sparing Mastectomy, Immediate Prosthesis Reconstruction, Endoscopic Surgery, Robotic Surgery
Peking University People's Hospital
Observational
484
Beijing
2025-01-03
Recruiting
Nanjing Bioheng Biotech Co., Ltd.
Early Phase 1
18
Lianyungang
2025-01-03
Recruiting
A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies
NCT06718634Relapsed or Refractory Lymphoid Malignancies
DrugBL-M08D1
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Harbin
2025-01-02
Not yet open
Yanbu Ke
Not applicable
100
Hangzhou
2025-01-02
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2025-01-02
Active, closed
Xing Liu
Not applicable
150
Chongqing
2025-01-02
Recruiting
Qifu Li
Observational
521
Chongqing
2025-01-02
Not yet open
The Affiliated Hospital of Qingdao University
Phase 1
32
Qingdao
2025-01-02
Active, closed
Weidong Tong
Observational
548
China
2025-01-01
Recruiting
The Second Affiliated Hospital of Kunming Medical University
Observational
717
Kunming
2025-01-01
By invitation
Beijing Chao Yang Hospital
Not applicable
276
Beijing
2025-01-01
Recruiting
TACS on High-inflammatory and Refractory Depression
NCT06812923Treatment Resistant Depression (TRD), Inflammation
Tianjin Anding Hospital
Not applicable
52
Tianjin
2025-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
60
Hangzhou
2025-01-01
Not yet open
Zhongnan Hospital
Not applicable
60
Wuhan
2025-01-01
Not yet open
Compound Danshen Dripping Pill for Diabetic Microvascular Angina
NCT06727890Diabetic Microvascular Angina
Qilu Hospital of Shandong University
Phase 4
162
Jinan
2025-01-01
Active, closed
Fudan University
Observational
3,000
Shanghai
2025-01-01
Recruiting
Juan Jiao
Not applicable
60
Beijing
2025-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
58
Nanjing
2025-01-01
Recruiting
Changzhi People's Hospital Affiliated to Changzhi Medical College
Observational
170
Changzhi
2025-01-01
Not yet open
Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.
NCT06772428Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors
DrugNano-crystalline Megestrol Acetate
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
96
Chengdu
2025-01-01
Recruiting
Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules
NCT07895277Pulmonary Nodules, Lung Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
6,000
Wuhan
2025-01-01
Recruiting
Fujian Medical University Union Hospital
Observational
100
Fuzhou
2025-01-01
Recruiting
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
NCT06316557Post-stroke Cognitive Impairment, Ischemic Stroke
Zi-Xiao Li
Not applicable
70
Beijing
2025-01-01
Recruiting
XiaoJing Zou,MD
Not applicable
26
Wuhan
2025-01-01
Recruiting
Dupilumab Therapy for EGIDs
NCT07257835Eosinophilic Gastrointestinal Disorders (EGIDs)
Children's Hospital of Fudan University
Observational
20
Shanghai
2025-01-01
Recruiting
Jiangxi Provincial Cancer Hospital
Phase 2
109
Nanchang
2025-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
800
Nanjing
2025-01-01
Recruiting
Shenzhen University General Hospital
Phase 1/2
20
Shenzhen
2025-01-01
Active, closed
O-RADS MRI System on Early Detection of Ovarian Cancer
NCT07009743Ovarian Cancer (OvCa), Ovarian Cancer Metastatic
Shanghai Gynecologic Oncology Group
Observational
2,549
Shanghai
2025-01-01
By invitation
Affiliated Hospital of Jiaxing University
Not applicable
126
Jiaxing
2025-01-01
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
358
Shijiazhuang, Zhengzhou, Jinan, Chengdu
2025-01-01
Recruiting
Ruijin Hospital
Observational
400
Shanghai
2025-01-01
Active, closed
Ruijin Hospital
Observational
120
Shanghai
2025-01-01
Recruiting
Qilu Hospital of Shandong University
Observational
224
Jinan
2025-01-01
Active, closed
RT for Adenocarcinoma/Adenosquamous Carcinoma
NCT07153952Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Radiotherapy
Peking Union Medical College Hospital
Phase 1/2
60
Beijing
2025-01-01
Recruiting
Gang Wang
Not applicable
214
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jining, Chengdu, Tianjin, Dali
2025-01-01
Recruiting
Qilu Hospital of Shandong University
Observational
254
Jinan
2025-01-01
Recruiting
Beijing Tiantan Hospital
Observational
800
Beijing
2025-01-01
Recruiting
Anhui Provincial Hospital
Observational
10,000
Anqing, Bengbu, Bozhou, Chizhou, Chuzhou, Fuyang, Hefei, Huaibei
2025-01-01
Active, closed
Mingzhao Xiao
Observational
1,000
Chongqing
2025-01-01
Recruiting
Eye & ENT Hospital of Fudan University
Observational
120
Shanghai
2025-01-01
Recruiting
Eastern Hepatobiliary Surgery Hospital
Phase 2
50
Shanghai
2025-01-01
Recruiting
Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury
NCT07106060SCI - Spinal Cord Injury, Motor Imagery, Brain-Computer Interfaces
Shengjing Hospital
Not applicable
36
Shenyang
2025-01-01
By invitation
Band Versus Ring for Tricuspid Regurgitation
NCT04093297Tricuspid Regurgitation
Nanjing Medical University
Not applicable
300
Nanjing
2025-01-01
Recruiting
HVA vs IA/DA or VA in the Treatment of ND HR-AML
NCT06810791Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University
Phase 3
876
Guangzhou
2025-01-01
Recruiting
Peking University Cancer Hospital & Institute
Observational
30
Beijing
2025-01-01
Recruiting
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
NCT06900647Metastatic Breast Cancer, Recurrent Breast Cancer
DrugsCDDP·Bortezomib·Cisplatin
Sun Yat-sen University
Phase 1
20
Guangzhou
2025-01-01
By invitation
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
By invitation
First Affiliated Hospital of Ningbo University
Phase 4
100
Ningbo
2025-01-01
By invitation
Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery
NCT06747546Congenital Heart Disease (CHD), Cardiopulmonary Bypass, Children, Oxygen Delivery
Children's Hospital of Fudan University
Not applicable
300
Minhang
2025-01-01
Recruiting
Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
NCT06965231Melanoma of Skin, Acral Melanoma, Stage II Melanoma
DrugsEndostar·Toripalimab
Fudan University
Phase 2
58
Shanghai
2025-01-01
Active, closed
Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
NCT06762470Histopathological Diagnosis of Nasopharyngeal Carcinoma, Patients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Jiangxi Provincial Cancer Hospital
Observational
325
Nanchang
2025-01-01
By invitation
Prognostic Value of TIL in Nasopharyngeal Carcinoma
NCT06763640Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital
Observational
216
Nanchang
2025-01-01
Recruiting
The Association Between Core Temperature and Health
NCT06432491Body Temperature Changes, Body Composition, Aging
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Not applicable
36
Shenzhen
2025-01-01
Recruiting
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
NCT07187908Primary/Secondary Prevention, High Risk for Febrile Neutropenia of Chemotherapy Regimens, Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
DrugEfbemalenograstim alfa
Henan Cancer Hospital
Phase 2
1,076
Zhengzhou
2025-01-01
By invitation
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
NCT07679776Systemic Lupus Erythematosus (SLE), Visual Function
The First Affiliated Hospital of Anhui Medical University
Observational
100
Hefei
2025-01-01
By invitation
Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
NCT06947096Gastric Cancer, Para-Aortic Lymph Node Metastasis, Lymphatic Metastasis, Preoperative Imaging Assessment
Qun Zhao
Observational
120
Shijiazhuang
2025-01-01
Recruiting
Chinese PLA General Hospital
Phase 1
98
Beijing
2025-01-01
Recruiting
AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
NCT07263204Hypertrophic Cardiomyopathy (HCM), Left Ventricular Hypertrophy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
15,000
Hangzhou
2025-01-01
Active, closed
Study on the Correlation Between Intraoperative Hypotension and Postoperative Myocardial Injury
NCT07094321Myocardial Injury After Noncardiac Surgery (MINS), Hypotension During Surgery
China-Japan Friendship Hospital
Observational
8,000
Beijing
2025-01-01
Recruiting
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916Renal Neoplasms, Pathology, Renal Cell Cancer
Shao Pengfei
Observational
2,100
Nanjing
2025-01-01
Recruiting
Fujian Cancer Hospital
Not applicable
76
Fuzhou
2025-01-01
Not yet open
Nanjing Medical University
Not applicable
120
Beijing, Nanjing
2025-01-01
Recruiting
Probiotics in Advanced Urothelial Carcinoma
NCT06904573Advanced Urothelial Carcinoma, Probiotics, Immunotherapy
DrugsEnfortumab Vedotin·Disitamab Vedotin·Toripalimab·Nab-paclitaxel
Sun Yat-sen University
Phase 2
222
Guangzhou, Wuhan
2025-01-01
Recruiting
Optic Nerve Injury in Obstructive Sleep Apnea Patients
NCT06748703Obstructive Sleep Apnea (OSA), Ischemic Optic Neuropathy/Optic Nerve Stroke
Nanjing Medical University
Not applicable
80
Nanjing
2025-01-01
Recruiting
Fujian Cancer Hospital
Phase 3
474
Fuzhou
2025-01-01
Recruiting
Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC
NCT06752239Nasopharyngeal Carcinoma, Quality of Life, Thyroid Diseases, Radiotherapy Side Effect
Jiangxi Provincial Cancer Hospital
Phase 3
474
Nanchang
2025-01-01
Recruiting
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
NCT07463872Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas, Intraductal Papillary Mucinous Neoplasm of Pancreas, Pseudocyst Pancreas
Huazhong University of Science and Technology
Observational
500
Wuhan
2025-01-01
Recruiting
PUL vs TURP in BPH Patients With Urinary Retention
NCT06037356BPH With Urinary Obstruction
Queen Mary Hospital, Hong Kong
Not applicable
100
Hong Kong
2025-01-01
Recruiting
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
NCT07101588Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Chinese PLA General Hospital
Phase 4
200
Beijing
2025-01-01
Recruiting
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2025-01-01
Recruiting
Affiliated Hospital of Nantong University
Not applicable
600
Nantong
2025-01-01
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
NCT06898398Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer, Surgery
Sun Yat-sen University
Observational
326
Beijing
2025-01-01
Recruiting
West China Hospital
Phase 2/3
32
Chengdu
2025-01-01
By invitation
The University of Hong Kong-Shenzhen Hospital
Observational
50
Shenzhen
2025-01-01
Recruiting
Shao Pengfei
Observational
300
Nanjing
2025-01-01
Recruiting
Sheng Zhang
Phase 2
84
Shanghai
2025-01-01
Not yet open
Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction
NCT06717204HFrEF - Heart Failure With Reduced Ejection Fraction, Myocardial Infarction (MI)
DrugVericiguat
Qilu Hospital of Shandong University
Observational
210
Jinan
2025-01-01
Active, closed
Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma
NCT06770699Nasopharyngeal Cancinoma (NPC)
Jiangxi Provincial Cancer Hospital
Observational
260
Nanchang
2025-01-01
Recruiting
Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease
NCT06890702Ischemic Stroke, Ischemic Cerebrovascular Disease
Tongji Hospital
Observational
7,000
Wuhan
2025-01-01
Not yet open
Xiuli Zuo
Observational
30
Jinan
2025-01-01
Active, closed
Second Xiangya Hospital of Central South University
Observational
700
Changsha
2025-01-01
Active, closed
Analysis of Immediate Urinary Continence Predictors After RS-RARP
NCT06850116Prostate Cancer (Post Prostatectomy), Urinary Continence, Retzius-sparing Robot-assisted Radical Prostatectomy
First Affiliated Hospital of Fujian Medical University
Observational
400
Fuzhou
2025-01-01
Recruiting
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
NCT06754488Posterior Bladder Wall Reconstruction, Anterior Bladder Wall Reconstruction, Anterior Bladder Wall Suspension
Suzhou Municipal Hospital
Not applicable
120
Suzhou
2025-01-01
Recruiting
Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer
NCT07124754T1 Gastric Cancer Lymph Node Metastasis Early Gastric Cancer Artificial Intelligence-Assisted Diagnosis Multimodal Data Integration
Qun Zhao
Observational
300
Shijiazhuang
2025-01-01
By invitation
Metabolic Characteristics of Plasma OxPLs in STEMI Patients.
NCT07382700STEMI - ST-segment Elevation Myocardial Infarction
First Affiliated Hospital of Ningbo University
Observational
240
Ningbo
2025-01-01
Not yet open
China-Japan Friendship Hospital
Not applicable
334
Beijing
2025-01-01
Recruiting
Peking University Cancer Hospital & Institute
Not applicable
50
Beijing
2025-01-01
By invitation
Zou Junjie
Not applicable
120
Shanghai
2025-01-01
Recruiting
Jin Yang
Not applicable
120
Shanghai
2025-01-01
Not yet open
Sun Yat-sen University
Phase 2/3
398
Guangzhou
2025-01-01
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
15
Shanghai
2025-01-01
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
20,000
Lincang
2025-01-01
Not yet open
China-Japan Friendship Hospital
Not applicable
98
Beijing
2025-01-01
Not yet open
Ruijin Hospital
Observational
200
Shanghai
2025-01-01
Recruiting
Fu Wai Hospital, Beijing, China
Observational
10,000
Beijing
2025-01-01
Recruiting
Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
NCT07586787Proliferative Diabetic Retinopathy (PDR)
Xiamen Ophthalmology Center Affiliated to Xiamen University
Not applicable
100
Beijing, Xiamen, Zhengzhou, Nanjing, Dalian
2025-01-01
Not yet open
West China Hospital
Phase 2
50
Chengdu
2025-01-01
Active, closed
Shanghai Zhongshan Hospital
Phase 1
3
Shanghai
2025-01-01
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165Immune-related Adverse Event, Neoadjuvant Therapy, dMMR Colorectal Cancer
Xijing Hospital
Observational
100
Xi'an
2025-01-01
Recruiting
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-01-01
Active, closed
Second Affiliated Hospital of Nanchang University
Phase 4
80
Nanchang
2025-01-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
30
Nanjing
2025-01-01
Active, closed
Tianjin Medical University
Phase 4
30
Tianjin
2025-01-01
Recruiting
Xiangya Hospital of Central South University
Observational
240
Changsha
2025-01-01
Not yet open
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1
12
Wuhan
2025-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 3
316
Shanghai
2025-01-01
Recruiting
Second Xiangya Hospital of Central South University
Not applicable
3,000
Beijing, Guangzhou, Shenzhen, Luoyang, Changsha, Nanjing, Shenyang, Chengdu
2025-01-01
Not yet open
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
NCT06745219Thrombopenia, Cervical Cancer, Radiotherapy Side Effect, Chemotherapeutic Toxicity
DrugHerombopag
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-01-01
Not yet open
Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors
NCT06742593Brain (Nervous System) Cancers, Brain and Central Nervous System Tumors, Brain Tumors
DrugMT027 cells
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1
12
Beijing
2025-01-01
Recruiting
Peking University Third Hospital
Observational
2,000
Beijing
2025-01-01
Recruiting
Qilu Hospital of Shandong University
Observational
266
Jinan
2025-01-01
Active, closed
Nanfang Hospital, Southern Medical University
Early Phase 1
30
Guangzhou
2025-01-01
Recruiting
TTE Improves Clinical Management of Stable Chest Pain
NCT07063147Transthorcic Echocardiography, Stable Angina Pectoris, Coronary Artery Disease, Major Adverse Cardiac Events
Tianjin Chest Hospital
Observational
50,000
Tianjin
2025-01-01
Not yet open
Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma
NCT06708650Hepatocellular Carcinoma, Radiotherapy, PD-1 Inhibitors
Guiping People's Hospital
Not applicable
50
Guiping
2025-01-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2025-01-01
Not yet open
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
Not yet open
High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
NCT06646211Primary Central Nervous System Lymphoma (PCNSL), Non Hodgkin Lymphoma (NHL)
Sun Yat-sen University
Phase 2
30
Guangzhou
2025-01-01
Recruiting
Beijing Friendship Hospital
Observational
869
Beijing
2025-01-01
Not yet open
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
44
Guangzhou
2025-01-01
Recruiting
Guangzhou Institute of Respiratory Disease
Phase 2
120
Guangzhou
2025-01-01
Not yet open
Daorong Wang
Not applicable
50
Yangzhou
2025-01-01
Not yet open
Xiao-dong Zhuang
Phase 4
200
Guangzhou
2025-01-01
Active, closed
Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
NCT06868758HER2 Positive Breast Carcinoma, Neoadjuvant Therapy
Chongqing General Hospital
Observational
50
Chongqing
2025-01-01
Recruiting
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
NCT07322783EGFR Positive Non-small Cell Lung Cancer, MET Amplification
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-01-01
By invitation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
3,000
Beijing
2025-01-01
Recruiting
Anhui Provincial Hospital
Observational
70
Hefei
2025-01-01
Recruiting
China-Japan Friendship Hospital
Not applicable
400
Xingtai, Zhengzhou, Baotou, Jinan, Datong, Kunming, Beijing
2025-01-01
By invitation
AI in Respiratory Disease Prevention, Diagnosis, and Triage
NCT06931782Respiratory Diseases, Artificial Intelligence (AI), Randomized Controlled Trial
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
2,400
Guangzhou
2025-01-01
Not yet open
Xuanwu Hospital, Beijing
Observational
1,000
Beijing
2025-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
150
Nanjing
2025-01-01
Not yet open
Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis
NCT06728046Idiopathic Scoliosis, Erector Spinae Plane Block, Patient Controlled Analgesia
West China Hospital
Not applicable
40
Chengdu
2025-01-01
Not yet open
Shanghai Chest Hospital
Not applicable
600
Shanghai
2025-01-01
Recruiting
Second Affiliated Hospital of Xi'an Jiaotong University
Phase 3
400
Xi'an
2025-01-01
Recruiting
Children's Hospital of Fudan University
Not applicable
200
Shanghai
2025-01-01
Recruiting
Nanjing Medical University
Observational
80
Nanjing
2025-01-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
120
Shanghai
2025-01-01
Recruiting
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
NCT06779058Chronic Hepatitis B, Liver Fibrosis
Shengjing Hospital
Observational
600
Shenyang
2025-01-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
394
Hangzhou, Shaoxing
2025-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
200
Hangzhou
2025-01-01
Recruiting
Fudan University
Not applicable
16,000
Shanghai
2025-01-01
Active, closed
The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes
NCT06997835Early Nursing Intervention, Gestational Diabetes Mellitus
Yan Lu
Not applicable
200
Nantong
2025-01-01
By invitation
Serum IGF1 on Female HFpEF Patients
NCT07015554HFpEF - Heart Failure With Preserved Ejection Fraction
The University of Hong Kong-Shenzhen Hospital
Observational
120
Shenzhen
2025-01-01
Recruiting
The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study
NCT07141056HCC - Hepatocellular Carcinoma, Psychological Distress, Immune Checkpoint Inhibitors (ICIs), Cancer, Treatment-Related
Guilin Medical University, China
Observational
700
Zhanjiang, Guilin, Shaoyang
2025-01-01
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
62
Guangzhou
2025-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2025-01-01
By invitation
First Affiliated Hospital of Ningbo University
Phase 4
200
Ningbo
2025-01-01
By invitation
AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
NCT06957678Gastric Cancer Adenocarcinoma Metastatic, Lymph Node Metastasis, Artificial Intelligence (AI) in Diagnosis
Qun Zhao
Observational
1,200
Shijiazhuang
2025-01-01
Recruiting
Remimazolam and Emergence Delirium in Pediatrics
NCT07046364Pediatric, Neurosurgery, Sevoflurane Anesthesia, Remimazolam
DrugRemimazolam
Peking University First Hospital
Phase 4
248
Beijing
2025-01-01
Recruiting
Children's Hospital of Fudan University
Phase 4
80
Shanghai
2025-01-01
Recruiting
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
NCT07297004Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
20
Guangzhou
2025-01-01
Not yet open
Subei People's Hospital of Jiangsu Province
Not applicable
238
Yangzhou
2025-01-01
Active, closed
Zhongnan Hospital
Not applicable
30
Wuhan
2025-01-01
Recruiting
Vitreous Zonule in Primary Angle-Closure Glaucoma
NCT07523139Primary Angle-Closure Glaucoma
Peking University People's Hospital
Observational
440
Beijing
2025-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
40
Beijing
2025-01-01
Not yet open
Peking University Third Hospital
Observational
250
Beijing
2025-01-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-01-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
300
Hangzhou
2025-01-01
Recruiting
Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden
NCT06769256ST-segment Elevation Myocardial Infarction (STEMI)
DrugTirofiban
Henan Institute of Cardiovascular Epidemiology
Phase 4
300
Zhengzhou
2025-01-01
By invitation
Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids
NCT07129005Uterine Fibroid, Uterine Sarcoma, Diagnose Disease, AI (Artificial Intelligence)
Tongji Hospital
Observational
520
Wuhan
2025-01-01
Recruiting
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173Rectal Neoplasms, Colon Neoplasms, Microbiota, Metagenome
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
300
Guangzhou
2025-01-01
Recruiting
Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients
NCT06740188Depressed Insomniac Co-morbid Patients
Tongji University
Phase 4
60
Shanghai
2025-01-01
Not yet open
China-Japan Friendship Hospital
Not applicable
1,040
Beijing
2025-01-01
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
84
Guangzhou
2025-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Not applicable
210
Shanghai
2025-01-01
Active, closed
Tianjin Eye Hospital
Observational
3,000
China
2025-01-01
Active, closed
Peking University People's Hospital
Observational
200
Beijing
2025-01-01
Recruiting
Fudan University
Phase 2
165
Fuzhou, Shanghai, Tianjin
2025-01-01
Not yet open
Nanjing Medical University
Not applicable
400
Beijing, Nanjing
2025-01-01
Recruiting
Ying Wang
Not applicable
216
Nantong
2025-01-01
Recruiting
Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk
NCT07090512Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
Bei Wang
Observational
27
Jinan
2025-01-01
Recruiting
Beijing Tiantan Hospital
Observational
2,000
Beijing
2025-01-01
Recruiting
Nanfang Hospital, Southern Medical University
Observational
420
Guangzhou
2025-01-01
Recruiting
Shanghai Mental Health Center
Phase 1/2
15
Shanghai
2025-01-01
Not yet open
Yongtao Sun
Phase 4
124
Jinan
2025-01-01
By invitation
Shanghai Atrial Fibrillation Registry
NCT06802965Atrial Fibrillation (AF)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
400,000
Shanghai
2025-01-01
Recruiting
Xijing Hospital
Observational
146
Xi'an
2025-01-01
Recruiting
Wen-zhao ZHONG
Phase 2
211
Guangzhou
2025-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
40
Beijing
2025-01-01
Recruiting
A Prospective Cohort Study of ITB Treatment for HSP
NCT06844734Hereditary Spastic Paraplegia
Shanghai 6th People's Hospital
Observational
50
Shanghai
2025-01-01
Recruiting
Henan Institute of Cardiovascular Epidemiology
Not applicable
2,146
Zhengzhou
2025-01-01
Recruiting
Jin Yang
Not applicable
400
Shanghai
2025-01-01
Not yet open
Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture
NCT06728033Hip Fractures, Ultrasound-guided Nerve Block, Perioperative Analgesia
DrugTramadol
West China Hospital
Not applicable
240
Chengdu
2025-01-01
Recruiting
Qilu Hospital of Shandong University
Observational
290
Heze, Jinan, Weifang
2025-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
166
Beijing
2025-01-01
Active, closed
Enhancing Nursing Skills With SimCapture Technology
NCT07143123Motivation, Clinical Skills Training, Nursing Students, OSCE (Objective Structured Clinical Examination)
China Medical University Hospital
Not applicable
170
2025-01-01
Not yet open
Peking University Cancer Hospital & Institute
Observational
30
Beijing
2025-01-01
By invitation
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
NCT07176091Parkinsonism, Transcranial Magnetic Stimilation, Intermittent Theta Burst Stimulation, Primary Motor Cortex
Second Affiliated Hospital of Soochow University
Not applicable
90
Suzhou
2025-01-01
Recruiting
Kong Fanming
Phase 2/3
405
Tianjin
2025-01-01
Not yet open
Wuhan Optics Valley Vcanbiopharma Co., Ltd.
Phase 1/2
149
Wuhan
2025-01
Recruiting
Fujian Medical University Union Hospital
Phase 2
20
Fuzhou
2025-01
Not yet open
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions
NCT06753318Pancreatic Cancer, Pancreatitis, Pancreatic Neuroendocine Neoplasms (pNETs), Autoimmune Pancreatitis
Huazhong University of Science and Technology
Not applicable
716
Wuhan
2025-01
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Beijing
2025-01
Not yet open
ZHOU Yidong
Observational
600
Beijing
2025-01
Not yet open
Peking University Sixth Hospital
Not applicable
60
Beijing
2025-01
Recruiting
Shenzhen Celconta Life Science Co., Ltd.
Phase 1
18
Anyang
2025-01
Not yet open
InnoBM Pharmaceuticals Co., Ltd.
Phase 3
228
Bengbu, Anyang, Zhengzhou, Nanjing, Lishui, Guangzhou, Lanzhou, Luoyang
2025-01
Recruiting
Peking Union Medical College Hospital
Observational
400
Beijing
2025-01
Not yet open
Sinocelltech Ltd.
Phase 1/2
99
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning
2025-01
Not yet open
LanZhou University
Not applicable
134
Lanzhou
2025-01
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
130
Tianjin
2025-01
Not yet open
RenJi Hospital
Not applicable
10
Shanghai
2025-01
Not yet open
Guangdong Provincial People's Hospital
Early Phase 1
40
Guangzhou
2025-01
Not yet open
Chinese Medical Association
Observational
600
Nanjing
2025-01
Not yet open
A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.
NCT06717009Kidney Neoplasms / Surgery, Robotic Surgical Procedures, Imaging, Three-Dimensional / Methods, Nephrectomy / Methods
Tianjin Medical University Cancer Institute and Hospital
Not applicable
350
Tianjin
2025-01
Recruiting
Zhifen Liu
Not applicable
100
Taiyuan
2024-12-31
By invitation
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
60
Nanjing
2024-12-31
Not yet open
Wuhan Createrna Science and Technology Co., Ltd
Phase 2
72
Beijing
2024-12-31
Active, closed
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
400
Guangzhou
2024-12-31
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2
80
Wuhan
2024-12-31
Recruiting
Fudan University
Observational
624
Shanghai
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
5,000
Xi'an
2024-12-31
Recruiting
Ruijin Hospital
Observational
1,500
Shanghai
2024-12-31
By invitation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
556
Guangzhou, Shantou
2024-12-31
Recruiting
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
NCT06783569Solid Tumors, Gastric Cancer, Esophagogastric Juction Cancer, Colorectal Cancer
JiaRay Group
Phase 1
94
Harbin, Shenyang
2024-12-31
By invitation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
128
Nanjing
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-12-31
Recruiting
Ruijin Hospital
Phase 1
29
Shanghai
2024-12-31
Not yet open
Zhejiang Cancer Hospital
Phase 2
58
Hangzhou
2024-12-31
Recruiting
Shixiu Wu
Phase 2
35
Quzhou
2024-12-31
Recruiting
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
198
Guangzhou
2024-12-31
Recruiting
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554HBV Related Acute-on-chronic Liver Failure, HBV-related Liver Cirrhosis, HBV (Hepatitis B Virus)
Qilu Hospital of Shandong University
Observational
100
Jinan
2024-12-31
Not yet open
Xijing Hospital
Phase 2/3
340
Xi'an
2024-12-31
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-31
Recruiting
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
NCT06849180Combined Hepatocellular-cholangiocarcinoma, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma
Zhongda Hospital
Observational
198
Nanjing
2024-12-31
Recruiting
Changhai Hospital
Phase 1
19
Shanghai
2024-12-31
Recruiting
Beijing Tsinghua Chang Gung Hospital
Phase 4
398
Beijing
2024-12-31
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
48
Shanghai
2024-12-31
By invitation
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
300
Nanjing
2024-12-31
Recruiting
Xu Yan
Not applicable
64
Chongqing
2024-12-31
Active, closed
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
258
Chuzhou, Hefei, Huainan, Beijing, Lanzhou, Foshan, Guangzhou, Jiangmen
2024-12-31
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
29
Shanghai
2024-12-31
Not yet open
Xuanwu Hospital, Beijing
Phase 4
532
Beijing
2024-12-31
Not yet open
Ruijin Hospital
Phase 2
34
Shanghai
2024-12-31
Recruiting
Xuanwu Hospital, Beijing
Not applicable
85
Beijing
2024-12-31
Not yet open
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
NCT06738745Prostate Cancer Metastatic Disease
DrugsHRS-2189·HRS-5041
Fudan University
Phase 2
90
Shanghai
2024-12-31
Recruiting
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
NCT06581419Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer
DrugIAP0971
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2
78
Beijing
2024-12-31
Recruiting
West China Hospital
Phase 1/2
57
Chengdu
2024-12-31
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2024-12-31
Recruiting
Zhejiang Wenda Pharma Technology LTD.
Phase 2
140
Nanjing
2024-12-31
Recruiting
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2024-12-31
Recruiting
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
NCT06883539Solid Tumor Malignancies, Cancer, Solid Cancers, Solid Tumor Cancer, Solid Tumor, Unspecified, Adult
LaunXP Biomedical Co., Ltd.
Phase 1
24
2024-12-31
Recruiting
Sun Yat-sen University
Phase 2
57
Guangzhou
2024-12-31
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
180
Nanjing
2024-12-31
Recruiting
Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque
NCT07660419Coronary Artery Disease (CAD), Coronary Stenosis
China National Center for Cardiovascular Diseases
Not applicable
176
Beijing
2024-12-31
Not yet open
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
NCT06762223Metabolic Dysfunction-associated Steatotic Liver Disease, Type 2 Diabetes Mellitus
DrugsHenagliflozin·Metformin
Xiqiao Zhou
Phase 4
190
Nanjing
2024-12-31
Recruiting
China National Center for Cardiovascular Diseases
Observational
300
Beijing
2024-12-31
Active, closed
Fudan University
Observational
197
Shanghai
2024-12-31
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-12-30
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1
40
Nanning, Haikou
2024-12-30
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 3
520
Baoding, Beijing, Changsha, Chengde, Chengdu, Guangzhou, Hangzhou, Kaifeng
2024-12-30
Recruiting
Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
NCT06876844Head and Neck Cancer, Head and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
24
Shanghai
2024-12-30
Recruiting
Shanghai Changzheng Hospital
Not applicable
16
Shanghai
2024-12-30
Active, closed
Gan & Lee Pharmaceuticals.
Phase 3
630
Beijing
2024-12-30
Not yet open
Targeted TDCS Intervention for Internet Gaming Disorder
NCT06759051Internet Gaming Disorder
Peking University
Not applicable
180
Beijing
2024-12-30
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
4,000
Xi'an
2024-12-30
Recruiting
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
480
Nanjing
2024-12-30
Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2
820
Beijing
2024-12-30
Not yet open
Yi Liang
Observational
400
Hangzhou
2024-12-30
Recruiting
Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
NCT06748352Early Gastric Cancer, Endoscopic Submucosal Dissection, Robot Surgery
Shandong University
Not applicable
50
Jinan
2024-12-30
Active, closed
Shanghai Dynaheart Medtech Co., Ltd.
Not applicable
254
Jilin City, Shanghai
2024-12-30
Active, closed
Ruijin Hospital
Phase 1/2
10
Shanghai
2024-12-30
Not yet open
Beijing Anzhen Hospital
Observational
10,000
Beijing
2024-12-30
Active, closed
Juan Li
Observational
400
Zhengzhou
2024-12-30
Recruiting
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
NCT07085650Atrial Fibrillation (AF), Mitral Regurgitation, Tricuspid Regurgitation
First Hospital of China Medical University
Observational
2,000
Shenyang
2024-12-30
By invitation
Caigang Liu
Not applicable
2,000
Shenyang
2024-12-30
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
2024-12-30
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
300
Guangzhou
2024-12-30
Recruiting
Shandong Provincial Hospital
Phase 2
32
Jinan
2024-12-30
Recruiting
Hunan Cancer Hospital
Phase 2
30
Changsha
2024-12-30
Active, closed
Suzhou HepaThera Biotech Co., Ltd.
Phase 1/2
86
Beijing, Xiamen, Guangzhou, Qingyuan, Shanghai, Chengdu
2024-12-30
Not yet open
Wuhan Createrna Science and Technology Co., Ltd
Phase 3
810
Beijing
2024-12-30
Recruiting
Effect of Subanesthetic Dose of Esketamine on Sleep Quality
NCT06773143Insomnia, Breast Cancer Surgery, Esketamine
DrugEsketamine
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing
2024-12-30
Active, closed
Boehringer Ingelheim
Phase 2
90
Guangzhou
2024-12-30
Recruiting
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
NCT06745687High Risk Smoldering Multiple Myeloma
DrugCM336
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
20
Tianjin
2024-12-30
Recruiting
Aibin Liang，MD，Ph.D.
Phase 1
24
Shanghai
2024-12-30
Not yet open
Shanghai Public Health Clinical Center
Early Phase 1
60
Shanghai
2024-12-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
190
Hefei, Fuzhou, Zhengzhou, Changsha, Nanchang, Jinan, Hangzhou
2024-12-30
Recruiting
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
130
Yiwu
2024-12-30
Not yet open
Akeso
Phase 2
24
Dongguan, Guangzhou, Shenzhen, Changsha, Ningbo
2024-12-30
Not yet open
Henan Cancer Hospital
Observational
100
Zhengzhou
2024-12-30
Recruiting
Effectiveness of Personalized Alternating Current Stimulation for Treating Emotional Disorders in CNS Demyelination Patients
NCT06933537Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing
Not applicable
65
Beijing
2024-12-29
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
92
Nanjing
2024-12-28
Recruiting
Jemincare
Phase 1
30
Beijing
2024-12-28
Recruiting
Nanjing Children's Hospital
Phase 1
12
Nanjing
2024-12-28
Recruiting
Liposomal Irinotecan and Apatinib in ES-SCLC
NCT06749691Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2024-12-28
Not yet open
Zhejiang University
Observational
20
Hangzhou
2024-12-28
Not yet open
Henan Cancer Hospital
Observational
80
Zhengzhou
2024-12-28
Active, closed
The First Affiliated Hospital of Nanchang University
Not applicable
30
Nanchang
2024-12-28
Not yet open
Application of Antiosteoporosis Therapy in Osteolysis
NCT05617846Limb; Fusion, Complication
Henan Cancer Hospital
Observational
100
Zhengzhou
2024-12-28
Active, closed
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT06743646Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
DrugZVS101e
Chigenovo Co., Ltd
Phase 3
63
Beijing, Guangzhou, Zhengzhou, Chengdu, Tianjin
2024-12-27
Recruiting
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
NCT06566079Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
InSilico Medicine Hong Kong Limited
Phase 1/2
160
Zhengzhou, Shanghai, Beijing, Guangzhou
2024-12-27
By invitation
TAF vs TDF During the Pregancy
NCT07542951Hepatitis B Virus Infection; Pregnant Women
The Third Affiliated Hospital of Guangzhou Medical University
Phase 4
210
Guangzhou
2024-12-27
Recruiting
Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
NCT06446154Hepatocellular Carcinoma, Immune Checkpoint Inhibitors, Anti-angiogenic Therapy, Second-line Treatment
DrugFruquintinib
Sun Yat-sen University
Phase 2
36
Guangzhou
2024-12-27
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
NCT06794008Systemic Lupus Erythematosus, Inflammatory Myopathy, Systemic Sclerosis (SSc), ANCA-associated Vasculitis
Peking University People's Hospital
Phase 2
50
Beijing
2024-12-26
Recruiting
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
30
Beijing, Xi'an
2024-12-26
Recruiting
A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
NCT07547787Locally Advanced Unresectable or Metastatic Gastric Cancer
Akeso
Observational
610
Beijing
2024-12-26
Recruiting
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593Monoclonal Gammopathy of Undetermined Significance (MGUS), Intestinal Flora, Multiple Myeloma, M-Protein
Zhujiang Hospital
Observational
2,990
Guanzhou
2024-12-26
Recruiting
Jie Li
Not applicable
200
Chengdu
2024-12-26
Active, closed
Amgen
Phase 2
61
Beijing, Fuzhou, Zhengzhou, Wuhan, Changsha, Changchun, Jinan, Shanghai
2024-12-26
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
74
Hangzhou
2024-12-26
Recruiting
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
NCT06937567Biliary Tract Cancer, Colorectal Carcinoma, Gastric Cancer, Metastatic, Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
Zhejiang University
Early Phase 1
36
Hangzhou
2024-12-26
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2024-12-26
Recruiting
Chen Suning
Phase 1/2
135
Suzhou
2024-12-25
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658Lymphoma, T-Cell, NK-LGL Leukemia, T-LGL Leukemia, Cutaneous T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
48
Tianjin
2024-12-25
Not yet open
Detachable String Magnetically Controlled Capsule Endoscopy for Patients with AUGIB
NCT06725056Acute Upper Gastrointestinal Bleeding, Capsule Endoscopes
Changhai Hospital
Not applicable
120
Shanghai
2024-12-25
Not yet open
Energenx Medical LTD.
Not applicable
10
Shanghai
2024-12-25
By invitation
IIT Study on the Use of Medical Bio Glue for Repairing Meniscus Tears
NCT06878794Unilateral Meniscus Tear of the Knee Joint
First Affiliated Hospital of Ningbo University
Not applicable
60
Ningbo
2024-12-25
By invitation
Tianjin Central Hospital of Gynecology Obstetrics
Observational
600
Tianjin
2024-12-25
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
96
Hangzhou
2024-12-25
Recruiting
CytosinLab Therapeutics Co., Ltd.
Phase 1/2
224
Beijing
2024-12-25
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 1
21
Tianjin
2024-12-25
Recruiting
China-Japan Friendship Hospital
Observational
500
Beijing, Wuhan
2024-12-25
Recruiting
Shengjing Hospital
Not applicable
60
Shenyang
2024-12-25
Not yet open
Shanghai Chest Hospital
Not applicable
600
Shanghai
2024-12-25
Recruiting
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
NCT06755567Head and Neck Cancer, Neoadjuvant Therapy, Immunotherapy, Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
750
Guangzhou
2024-12-25
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
30
Nanjing
2024-12-25
Not yet open
Fudan University
Phase 2
141
Shanghai
2024-12-25
Recruiting
Energenx Medical LTD.
Not applicable
126
Shanghai
2024-12-25
Recruiting
Total Infectome Characterization of Eye Infections
NCT06775808Eye Infections, Diagnosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2024-12-25
Recruiting
Shanghai AbelZeta Ltd.
Phase 1
24
Shanghai
2024-12-25
Active, closed
First Affiliated Hospital, Sun Yat-Sen University
Observational
700
Guangzhou
2024-12-25
Recruiting
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2
70
Yiwu
2024-12-25
Active, closed
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Phase 2
161
Zhongshan
2024-12-24
Recruiting
Shanghai Mental Health Center
Not applicable
90
Shanghai
2024-12-24
Recruiting
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
100
Lanzhou
2024-12-24
Recruiting
An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
NCT07033156CRC (Colorectal Cancer), Adenoma Colon
Zhejiang Provincial People's Hospital
Observational
450
Hangzhou
2024-12-24
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
20
Guangzhou
2024-12-24
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
64
Shanghai
2024-12-24
By invitation
Mingjian Ge
Not applicable
104
Chongqing
2024-12-24
Recruiting
Zhejiang University
Early Phase 1
36
Hangzhou
2024-12-24
Active, closed
Beijing Tiantan Hospital
Not applicable
224
Beijing
2024-12-24
Recruiting
Ractigen Therapeutics.
Phase 1
32
Beijing, Chengdu, Hangzhou
2024-12-24
Recruiting
Rakuten Medical, Inc.
Phase 3
412
2024-12-24
Recruiting
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
NCT06761027Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer
DrugsAnlotinib·Sintilimab
Fujian Provincial Hospital
Phase 1/2
29
Fuzhou, Zhangzhou
2024-12-23
Recruiting
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse
Drug[18F]RCCB6
RenJi Hospital
Phase 2
300
Shanghai
2024-12-23
Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma, Bladder Cancer
Drugs[68Ga]Ga-NOTA-RT4·[18F]F-RESCA-RT4·[18F]F-RESCA-T4·[68Ga]Ga-NOTA-T4
RenJi Hospital
Phase 2/3
400
Shanghai
2024-12-23
Recruiting
Ruijin Hospital
Early Phase 1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
Sichuan University
Phase 2
202
Sichuan
2024-12-23
Recruiting
Kezhong Zhang
Not applicable
12
Nanjing
2024-12-23
By invitation
Shanghai Pulmonary Hospital, Shanghai, China
Observational
308
Shanghai
2024-12-23
Recruiting
Xuanwu Hospital, Beijing
Early Phase 1
15
Beijing
2024-12-23
Recruiting
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
NCT07002398Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
VeonGen Therapeutics GmbH
Phase 1/2
18
Shanghai
2024-12-23
Recruiting
Waterstone Pharmaceutical (Wuhan) Co., LTD.
Phase 3
420
Bengbu, Wuhu, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhanjiang, Huizhou
2024-12-23
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
200
Guangzhou
2024-12-23
Recruiting
Efficacy and Safety of Colorectal Anastomotic Leak Testing
NCT06865638Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications
Nanchong Central Hospital
Not applicable
264
Nanchong
2024-12-22
Recruiting
Xingchen Peng
Phase 1/2
158
Chengdu
2024-12-22
Recruiting
Guangdong Provincial People's Hospital
Phase 2
46
Guangzhou
2024-12-22
Recruiting
Peking Union Medical College Hospital
Phase 3
90
Beijing
2024-12-20
Recruiting
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT06715007Stroke, Ischemic, Small Vessel Cerebrovascular Disease, White Matter Hyperintensity
DrugsCilostazol·Clopidogrel·Aspirin
The First Affiliated Hospital with Nanjing Medical University
Observational
300
Nanjing
2024-12-20
Active, closed
Xinhong Wu, PhD
Phase 2
40
Wuhan
2024-12-20
Not yet open
RenJi Hospital
Not applicable
92
Shanghai
2024-12-20
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Observational
119
Wenzhou
2024-12-20
Active, closed
Coherus Oncology, Inc.
Phase 2
72
2024-12-20
Recruiting
HAPA-based Intervention in Adults With Metabolic Syndrome and Chronic Kidney Disease
NCT06715735Chronic Kidney Diseases, Metabolic Syndrome
Chinese University of Hong Kong
Not applicable
160
Chengdu
2024-12-20
Recruiting
Gan & Lee Pharmaceuticals.
Phase 3
240
Beijing
2024-12-20
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 1
12
Beijing, Guangzhou, Hangzhou
2024-12-20
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-12-20
Rows per page Showing 10501–11000 of 19187
Previous 20 21 22 23 24 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china?page=22

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)
→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.